![Parand Darou Pharma](https://www.pharmacompass.com/image/flap/parand-darou-desktop-headergif-12950.gif)
![Parand Darou Pharma](https://www.pharmacompass.com/image/flap/parand-darou-mobgif-20656.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/28/2888940/0/en/Avalyn-to-Participate-in-Jefferies-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/05/20/2885153/0/en/Avalyn-Presents-Clinical-Data-on-AP01-for-Pulmonary-Fibrosis-Including-Long-Term-Efficacy-and-Imaging-Biomarker-Data-at-ATS-2024.html
https://www.globenewswire.com/news-release/2024/05/13/2880403/0/en/Avalyn-Announces-Multiple-Presentations-on-its-Lead-Program-AP01-for-Pulmonary-Fibrosis-and-its-Approach-to-Developing-Novel-Inhaled-Therapies-for-Lung-Diseases-at-the-2024-America.html
https://www.globenewswire.com/news-release/2024/05/01/2873177/0/en/Avalyn-Bolsters-Leadership-Team-with-the-Appointment-of-Douglas-Carlson-as-Chief-Financial-Officer-and-Chief-Business-Officer.html
https://www.globenewswire.com//news-release/2024/03/06/2841353/0/en/Avalyn-to-Participate-in-Leerink-Partners-Global-Biopharma-Conference.html
https://www.globenewswire.com//news-release/2024/02/06/2824272/0/en/Avalyn-to-Participate-in-Multiple-Upcoming-Investor-Conferences.html
https://www.globenewswire.com/news-release/2023/12/06/2791709/0/en/Avalyn-to-Participate-in-the-2023-RBC-Capital-Markets-Healthcare-Private-Company-Conference.html
https://www.globenewswire.com//news-release/2023/11/09/2777290/0/en/Avalyn-Presents-Data-from-its-AP01-and-AP02-Inhaled-Therapeutics-Programs-for-Pulmonary-Fibrosis.html
https://www.globenewswire.com//news-release/2023/11/06/2774069/0/en/Avalyn-Strengthens-Leadership-Team-with-Key-Appointments-including-Dr-Craig-Conoscenti-as-SVP-Clinical-Development-and-Jim-Bishop-as-SVP-Business-Operations.html
https://www.globenewswire.com//news-release/2023/10/05/2755333/0/en/Avalyn-to-Participate-in-Multiple-Upcoming-Investor-Conferences.html